CytomX Therapeutics
CTMX
CTMX
97 hedge funds and large institutions have $441M invested in CytomX Therapeutics in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 16 reducing their positions, and 15 closing their positions.
Holders
97
Holders Change
+7
Holders Change %
+7.78%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
23
Increased
38
Reduced
16
Closed
15
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$11.4M |
2 |
2
State Street
Boston,
Massachusetts
|
$15.5M |
3 |
3
BlackRock
New York
|
$37.4M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$20.9M |
5 |
BI
5
BVF Inc
San Francisco,
California
|
$40.5M |